Risk of Diabetic Ketoacidosis after Initiation of an SGLT2 Inhibitor
He cites as an example how, during the development of androgen-receptor targeted therapies, they used a novel form of PET/CT scanning that they had also been working on with fluoro-dihydrotestosterone (F18 [18F]-FDHT)), a type of radioactive testosterone, as part of dose-finding clinical trials of drugs like enzalutamide and apalutamide
El estudio SURMOUNT-4, dado a conocer durante la reunin de la Asociacin Europea para el Estudio de la Diabetes (EASD) , incluy 783 adultos con obesidad o sobrepeso, pero sin diabetes mellitus, que previamente estuvieron a tratamiento con tirzepatida durante 36 semanas
Cost is the driver the article identifies, describing a price gap for branded medications without insurance coverage that has fueled dangerous myths
Weight Loss The big question: When will I start losing weight
This was coupled with a decrease in expression and secretion of IGF-1, which could explain the lack of feedback inhibitory effect on pituitary GH secretion in the fasting state